CO-OCCURRENCE OF ANXIETY AND BIPOLAR DISORDERS: CLINICAL AND THERAPEUTIC OVERVIEW: Anxiety in Bipolar Disorder
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Anxiety commonly co-occurs with bipolar disorders (BDs), but the significance of such "co-morbidity" remains to be clarified and its optimal treatment adequately defined. METHODS: We reviewed epidemiological, clinical, and treatment studies of the co-occurrence of BD and anxiety disorder through electronic searching of Pubmed/MEDLINE and EMBASE databases. RESULTS: Nearly half of BD patients meet diagnostic criteria for an anxiety disorder at some time, and anxiety is associated with poor treatment responses, substance abuse, and disability. Reported rates of specific anxiety disorders with BD rank: panic ≥ phobias ≥ generalized anxiety ≥ posttraumatic stress ≥ obsessive-compulsive disorders. Their prevalence appears to be greater among women than men, but similar in types I and II BD. Anxiety may be more likely in depressive phases of BD, but relationships of anxiety phenomena to particular phases of BD, and their temporal distributions require clarification. Adequate treatment trials for anxiety syndromes in BD patients remain rare, and the impact on anxiety of treatments aimed at mood stabilization is not clear. Benzodiazepines are sometimes given empirically; antidepressants are employed cautiously to limit risks of mood switching and emotional destabilization; lamotrigine, valproate, and second-generation antipsychotics may be useful and relatively safe. CONCLUSIONS: Anxiety symptoms and syndromes co-occur commonly in patients with BD, but "co-morbid" phenomena may be part of the BD phenotype rather than separate illnesses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
The pre-therapeutic classification of co-morbidity in chronic disease
Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544 · cited 1×
“[7–11] The term “co-morbidity” is widely used to indicate co-occurrence in the same patient of symptoms meeting standard diagnostic criteria for more than one clinical condition.[12] However, this term can be confusing, particularly when applied to psychiatric disorders, due to symptomatic overlap among syndromes.”
BackgroundExcess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120
Perlis, R. H., Miyahara, S., Marangell, L. B., Wisniewski, S. R., Ostacher, M., DelBello, M. P., Bowden, C. L., Sachs, G. S., & Nierenberg, A. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.022 · Cited by 852 · cited 1×
“[5, 31, 44–52] Nearly half of BD patients studied have met standard diagnostic criteria for at least one anxiety disorder at some time[35, 42, 47, 48]; we found an average risk of 46.”
BackgroundComorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study
Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1394 · Cited by 677
Miklowitz, D. J., Otto, M. W., Frank, E., Reilly-Harrington, N. A., Wisniewski, S. R., Kogan, J. N., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Gyulai, L., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.419 · Cited by 537 · cited 12×
“Conclusions: Anxiety symptoms and syndromes co-occur commonly in patients with BD, but “co-morbid” phenomena may be part of the BD phenotype rather than separate illnesses.”
BackgroundInfluentialPsychiatric and Medical Comorbidities of Bipolar Disorder
Krishnan, K. R. R. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000151489.36347.18 · Cited by 502 · cited 2×
“It is especially uncertain when to rely primarily on mood-stabilizing treatments in hopes of ameliorating a range of psychopathological phenomena in BD patients, and when to consider alternative treatments or polytherapy directed at symptoms considered to represent discrete illnesses in need of separate treatments.[2,…”
BackgroundGrant, B. F., Stinson, F. S., Hasin, D. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Huang, B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1001 · Cited by 479
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Self-citationRelapse Prevention in Patients With Bipolar Disorder: Cognitive Therapy Outcome After 2 Years
Lam, D. H., Hayward, P., Watkins, E. R., Wright, K., & Sham, P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.324 · Cited by 347
“Psychiatric comorbidity”: an artefact of current diagnostic systems?
Maj, M. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.3.182 · Cited by 305 · cited 1×
“[13, 16–20] Moreover, fundamental reliance by the major international nosological systems on categorical diagnostic schemes virtually guarantees proliferation of clinical entities and high likelihood of meeting diagnostic criteria for multiple disorders in the same person.[13, 21, 22] In addition to its theoretical ch…”
BackgroundAngst, J., Cui, L., Swendsen, J., Rothen, S., Cravchik, A., Kessler, R. C., & Merikangas, K. R. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09071011 · Cited by 305 · cited 1×
“[3] The broad range of putative bipolar-like disorders occurs internationally at an estimated lifetime prevalence of up to 10% of the general population.[1, 4, 5] BDs of types I and II are among leading”
BackgroundSani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., et al. (2012) · CNS Drugs · doi:10.2165/11634390-000000000-00000 · Cited by 273
Mania associated with antidepressant treatment: comprehensive meta‐analytic review
Tondo, L., Vázquez, G., & Baldessarini, R. J. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01514.x · Cited by 256
Self-citationDenys, D., de Geus, F., van Megen, H. J. G. M., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0803 · Cited by 248
Anxiety as a Correlate of Response to the Acute Treatment of Bipolar I Disorder
Feske, U. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.956 · Cited by 230
Bystritsky, A., Ackerman, D. L., Rosen, R. M., Vapnik, T., Gorbis, E., Maidment, K. M., & Saxena, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0418 · Cited by 220 · cited 1×
“[132–134] Olanzapine has shown inconsistent effects in obsessive-compulsive disorder[135, 136] but has some evidence of efficacy in posttraumatic stress disorder.”
BackgroundImpact of Comorbid Anxiety Disorders on Outcome in a Cohort of Patients With Bipolar Disorder
Boylan, K. R., Bieling, P. J., Marriott, M., Begin, H., Young, L. T., & MacQueen, G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0813 · Cited by 215
Anxious and non-anxious bipolar disorder
Trevor Young, L., Cooke, R. G., Robb, J. C., Levitt, A. J., & Joffe, R. T. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90118-4 · Cited by 178
Riluzole in the Treatment of Mood and Anxiety Disorders
Pittenger, C., Coric, V., Banasr, M., Bloch, M., Krystal, J. H., & Sanacora, G. (2008) · CNS Drugs · doi:10.2165/00023210-200822090-00004 · Cited by 177 · cited 1×
“Promising preliminary findings have been reported for such diverse treatments as various antiglutamate agents: riluzole,[145, 146] the NMDA-glutamate receptor antagonist memantine developed to treat dementia,[147] and intranasal ketamine in juvenile BD with prominent fears of harm.”
BackgroundOffidani, E., Guidi, J., Tomba, E., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353198 · Cited by 166
Goldberg, D., & Fawcett, J. (2012) · Depression and Anxiety · doi:10.1002/da.21939 · Cited by 155 · cited 1×
“[5, 31, 44–52] Nearly half of BD patients studied have met standard diagnostic criteria for at least one anxiety disorder at some time[35, 42, 47, 48]; we found an average risk of 46.”
BackgroundHirschfeld, R. M. A., Weisler, R. H., Raines, S. R., Macfadden, W., & BOLDER Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0304 · Cited by 116 · cited 2×
“[102, 103] Quetiapine, which has beneficial effects in mania also was effective in depressed bipolar I or II disorder patients.[104] In a recent meta-analytic review, we found that quetiapine was 36% more effective for bipolar depression than placebo, compared to 25% for olanzapine, in five trials of each antipsychoti…”
BackgroundLi, X., May, R. S., Tolbert, L. C., Jackson, W. T., Flournoy, J. M., & Baxter, L. R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0610 · Cited by 110
Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine
Passmore, M. J., Garnham, J., Duffy, A., MacDougall, M., Munro, A., Slaney, C., Teehan, A., & Alda, M. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00026.x · Cited by 109
Fineberg, N. A., Sivakumaran, T., Roberts, A., & Gale, T. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200507000-00005 · Cited by 105
Baetz, M., & Bowen, R. C. (1998) · The Canadian Journal of Psychiatry · doi:10.1177/070674379804300109 · Cited by 96
Offidani, E., Fava, G. A., Tomba, E., & Baldessarini, R. J. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345316 · Cited by 94
Self-citationMcIntyre, R. S., Rosenbluth, M., Ramasubbu, R., Bond, D. J., Taylor, V. H., Beaulieu, S., & Schaffer, A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400209 · Cited by 70
Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety
Sheehan, D. V., McElroy, S. L., Harnett-Sheehan, K., Keck, P. E., Janavs, J., Rogers, J., Gonzalez, R., Shivakumar, G., & Suppes, T. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.005 · Cited by 69 · cited 2×
“PBO for panic or OCD in BD-I and BD-II and BD-NOS Ineffective [106]”
BackgroundDeckersbach, T., Peters, A. T., Sylvia, L., Urdahl, A., Magalhães, P. V. S., Otto, M. W., Frank, E., Miklowitz, D. J., Berk, M., Kinrys, G., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020225 · Cited by 65
Perugi, G., Toni, C., Frare, F., Ruffolo, G., Moretti, L., Torti, C., & Akiskal, H. S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00008 · Cited by 61
A population-based analysis of distinguishers of bipolar disorder from major depressive disorder
Schaffer, A., Cairney, J., Veldhuizen, S., Kurdyak, P., Cheung, A., & Levitt, A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.118 · Cited by 53
Treating Nonspecific Anxiety and Anxiety Disorders in Patients With Bipolar Disorder: A Review
Rakofsky, J. J., & Dunlop, B. W. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05815gre · Cited by 52
Maina, G., Albert, U., Rosso, G., & Bogetto, F. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0413 · Cited by 50
Sheehan, D. V., Harnett-Sheehan, K., Hidalgo, R. B., Janavs, J., McElroy, S. L., Amado, D., & Suppes, T. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.016 · Cited by 42
Hawke, L. D., Provencher, M. D., Parikh, S. V., & Zagorski, B. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800704 · Cited by 28 · cited 1×
“[24, 35, 48, 55, 65, 77, 80–87] Of particular clinical and public health significance, several studies have found that anxiety symptoms in BD patients were associated with substantially increased risks of suicidal ideation, attempts, and suicides,[35, 88–90] often in association with a more severe symptomatic course o…”
BackgroundSchaffer, A., & Cairney, J. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1119 · Cited by 21
Research works printed but not linked: 111
- Goodwin, 2007, Manic-Depressive Illness
- Baldessarini, 2010, Bipolar depression: overview and commentary, Harv Rev Psychiatry, 18, 143, 10.3109/10673221003747955 · DOI · Paper page
- Tondo, 2003, Suicidal behaviour in bipolar disorder: risk and prevention, CNS Drugs, 17, 491, 10.2165/00023210-200317070-00003 · DOI · Paper page
- Strakowski, 1998, Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after first psychiatric hospitalization, J Clin Psychiatry, 59, 465, 10.4088/JCP.v59n0905 · DOI · Paper page
- Kupfer, 2005, Increasing medical burden in bipolar disorder, JAMA, 293, 2528, 10.1001/jama.293.20.2528 · DOI · Paper page
- Fortin, 2007, Multimorbidity's many challenges, BMJ, 334, 1016, 10.1136/bmj.39201.463819.2C · DOI · Paper page
- Valderas, 2009, Defining comorbidity: implications for understanding health and health services, Ann Fam Med, 7, 357, 10.1370/afm.983 · DOI · Paper page
- Winokur, 1990, The concept of secondary depression and its relationship to comorbidity, Psychiatr Clin North Am, 13, 567, 10.1016/S0193-953X(18)30336-8 · DOI
- Praag, 1996, Comorbidity (psycho)analysed, Br J Psychiatry, 168, 129s, 10.1192/S0007125000298516 · DOI
- Wittchen, 1996, Critical issues in the evaluation of comorbidity of psychiatric disorders, Br J Psychiatry, 168, 9s, 10.1192/S000712500029836X · DOI · Paper page
- Praag, 1999, Impact psychopharmacology and biological psychiatry, Dialog Clin Neurosci, 1, 141, 10.31887/DCNS.1999.1.3/hmvanpraag · DOI
- Zimmerman, 1999, Psychiatric diagnosis in clinical practice: is comorbidity being missed, Compr Psychiatry, 40, 182, 10.1016/S0010-440X(99)90001-9 · DOI · Paper page
- American Psychiatric Association (APA), 1980, Diagnostic and Statistical Manual of Mental Disorders, editions 3 to 5 (DSM-III, DSM-III-R, DSM-IV, DSM-IV-TR, DSM-5)
- World Health Organization (WHO), 2014, International Statistical Classification of Diseases and Related Health Problems, eleventh edition (ICD-11)
- Yatham, 2013, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder, Bipolar Disord, 15, 1, 10.1111/bdi.12025 · DOI · Paper page
- Vázquez, 2013, Overview of antidepressant treatment in bipolar depression: critical commentary, Intl J Neuropsychopharmacol, 22, 1
- Baldessarini, 2013, Rate of new-onset mania or hypomania in patients diagnosed with unipolar major depression, J Affect Disord, 148, 129, 10.1016/j.jad.2012.10.033 · DOI · Paper page
- Goikolea, 2013, Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics vs. haloperidol, J Affect Disord, 144, 191, 10.1016/j.jad.2012.07.038 · DOI
- Provencher, 2012, Comorbid anxiety in bipolar spectrum disorders: a neglected research and treatment issue?, J Affect Disord, 137, 161, 10.1016/j.jad.2011.12.001 · DOI
- Chen, 1995, Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders, Psychiatry Res, 59, 57, 10.1016/0165-1781(95)02752-1 · DOI · Paper page
- Pini, 1997, Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia, J Affect Disord, 42, 145, 10.1016/S0165-0327(96)01405-X · DOI · Paper page
- Rihmer, 2001, Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary, J Affect Disord, 67, 175, 10.1016/S0165-0327(01)00309-3 · DOI
- Simon, 2003, Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression, J Psychiatr Res, 37, 187, 10.1016/S0022-3956(03)00021-9 · DOI
- Zimmermann, 2009, Heterogeneity of DSM-IV major depressive disorder as a consequence of sub-threshold bipolarity, Arch Gen Psychiatry, 66, 1341, 10.1001/archgenpsychiatry.2009.158 · DOI · Paper page
- Angst, 1998, Emerging epidemiology of hypomania and bipolar II disorder, J Affect Disord, 50, 143, 10.1016/S0165-0327(98)00142-6 · DOI · Paper page
- Chen, 1995, Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiology Catchment Area survey, Am J Psychiatry, 152, 280, 10.1176/ajp.152.2.280 · DOI · Paper page
- Kessler, 1997, Epidemiology of DSM-III-R bipolar I disorder in a general population survey, Psychol Med, 27, 1079, 10.1017/S0033291797005333 · DOI · Paper page
- Goodwin, 2002, Bipolar-panic comorbidity in the general population: prevalence and associated morbidity, J Affect Disord, 70, 27, 10.1016/S0165-0327(01)00398-6 · DOI
- Sala, 2012, Course of comorbid anxiety disorders among adults with bipolar disorder in the US population, J Psychiatr Res, 46, 865, 10.1016/j.jpsychires.2012.03.024 · DOI · Paper page
- McElroy, 2001, Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder, Am J Psychiatry, 158, 420, 10.1176/appi.ajp.158.3.420 · DOI · Paper page
- Henry, 2003, Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer, J Clin Psychiatry, 64, 331, 10.4088/JCP.v64n0316 · DOI · Paper page
- Simon, 2004, Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD), Am J Psychiatry, 161, 2222, 10.1176/appi.ajp.161.12.2222 · DOI · Paper page
- Kessler, 2005, Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication, Psychol Med, 35, 1073, 10.1017/S0033291705004538 · DOI · Paper page
- Kessler, 2005, Prevalence severity and comorbidity of 12 month DSM-IV disorders in the National Comorbidity Survey Replication, Arch Gen Psychiatry, 62, 617, 10.1001/archpsyc.62.6.617 · DOI · Paper page
- Kauer-Sant’Anna, 2009, Epidemiology and management of anxiety in patients with bipolar disorder, CNS Drugs, 23, 953, 10.2165/11310850-000000000-00000 · DOI
- Angst, 2011, Prevalence and characteristics of undiagnosed bipolar disorder in patients with major depressive episode, Arch Gen Psychiatry, 68, 791, 10.1001/archgenpsychiatry.2011.87 · DOI · Paper page
- Tsuang, 2002, Textbook in Psychiatric Epidemiology, 407, 10.1002/0471234311 · DOI · Paper page
- Keck, 1995, Outcome and comorbidity in first- compared with multiple-episode mania, J Nerv Ment Dis, 183, 320, 10.1097/00005053-199505000-00008 · DOI
- Krüger, 1995, Comorbidity of obsessive compulsive disorder in bipolar disorder, J Affect Disord, 34, 117, 10.1016/0165-0327(95)00008-B · DOI
- Dilsaver, 1997, Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania, Psychiatry Res, 73, 47, 10.1016/S0165-1781(97)00109-1 · DOI · Paper page
- Szádóczky, 1998, Prevalence of major depressive and bipolar disorders in Hungary: results from a National Epidemiologic Survey, J Affect Disord, 50, 153, 10.1016/S0165-0327(98)00056-1 · DOI · Paper page
- Baldassano, 2005, Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants, Bipolar Disord, 7, 465, 10.1111/j.1399-5618.2005.00237.x · DOI · Paper page
- Faravelli, 2006, Threshold and subthreshold bipolar disorders in the Sesta Fiorentino Study, J Affect Disord, 94, 111, 10.1016/j.jad.2006.01.031 · DOI
- Mantere, 2006, Differences in Axis I and II comorbidity between bipolar I and II disorders and major depressive disorder, J Clin Psychiatry, 67, 584, 10.4088/JCP.v67n0409 · DOI · Paper page
- Benedetti, 2007, Gender differences in bipolar disorder type I: 48 week prospective follow-up of 72 patients treated in an Italian tertiary care center, J Nerv Ment Dis, 195, 93, 10.1097/01.nmd.0000243781.67035.b1 · DOI
- Brieger, 2007, Dimensions underlying outcome criteria in bipolar I disorder, J Affect Disord, 99, 1, 10.1016/j.jad.2006.08.012 · DOI
- Albert, 2008, Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes, J Affect Disord, 105, 297, 10.1016/j.jad.2007.05.020 · DOI
- Altshuler, 2010, Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network, Am J Psychiatry, 167, 708, 10.1176/appi.ajp.2009.09010105 · DOI · Paper page
- Saunders, 2012, Clinical features of bipolar disorder comorbid with anxiety disorders differ between men and women, Depress Anxiety, 29, 739, 10.1002/da.21932 · DOI · Paper page
- Das, 2013, Anxiety disorders in bipolar I mania: prevalence, effect on illness severity, and treatment implications, Indian J Psychol Med, 35, 53, 10.4103/0253-7176.112202 · DOI
- Baldessarini, 2013, First-episode types in bipolar disorder: predictive associations with later illness, Acta Psychiatr Scand, 127, 355
- Fogarty, 1994, Epidemiology of psychiatric disorders in Edmonton, Acta Psychiatr Scand Suppl, 376, 16, 10.1111/j.1600-0447.1994.tb05787.x · DOI
- Salvatore, 2013, Antecedents of manic vs. other first psychotic episodes in 263 bipolar I disorder patients, Acta Psychiatr Scand, 10.1111/acps.12170 · DOI · Paper page
- Salvatore, 2013, Negative affective features in 516 cases of first psychotic disorder episodes: relationship to suicidal risk, J Depress Anxiety, 10.4172/2167-1044.1000131 · DOI
- Freeman, 2002, The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues, J Affect Disord, 68, 1, 10.1016/S0165-0327(00)00299-8 · DOI · Paper page
- McIntyre, 2007, Medical comorbidity in bipolar disorder: re-prioritizing unmet needs, Curr Opin Psychiatry, 20, 406, 10.1097/YCO.0b013e3281938102 · DOI · Paper page
- Mantere, 2010, Prospective latent analyses study of psychiatric comorbidity of DSM-IV bipolar I and II disorders, Bipolar Disord, 12, 271, 10.1111/j.1399-5618.2010.00810.x · DOI · Paper page
- Coryell, 2009, Anxiety and outcome in bipolar disorder, Am J Psychiatry, 166, 1238, 10.1176/appi.ajp.2009.09020218 · DOI · Paper page
- Parker, 2010, Comorbidities in bipolar disorder: models and management, Med J Austral, 193, s18
- Cazard, 2013, [Bipolar disorders and comorbid anxiety: prognostic impact and therapeutic challenges (French)], Encephale, 39, 66, 10.1016/j.encep.2012.04.005 · DOI
- Judd, 2003, Prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account sub-threshold cases, J Affect Disord, 73, 123, 10.1016/S0165-0327(02)00332-4 · DOI · Paper page
- Dickstein, 2005, Comorbid anxiety in phenotypes of pediatric bipolar disorder, J Child Adolesc Psychopharmacol, 15, 534, 10.1089/cap.2005.15.534 · DOI · Paper page
- Gaudiano, 2005, Anxiety disorder comorbidity in bipolar I disorder: relationship to depression severity and treatment outcome, Depress Anxiety, 21, 71, 10.1002/da.20053 · DOI · Paper page
- Keck, 2008, Clinical and economic effects of unrecognized or inadequately treated bipolar disorder, J Psychiatr Pract, 14, 31, 10.1097/01.pra.0000320124.91799.2a · DOI · Paper page
- Gao, 2010, Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders, Am J Addict, 19, 440, 10.1111/j.1521-0391.2010.00060.x · DOI · Paper page
- Hawke, 2013, Bipolar disorder with comorbid anxiety disorders: impact of comorbidity on treatment outcome in cognitive-behavioral therapy and psychoeducation, Int J Bipolar Disord, 1, 15, 10.1186/2194-7511-1-15 · DOI
- MacKinnon, 2003, Rapid switching of mood in families with multiple cases of bipolar disorder, Arch Gen Psychiatry, 60, 921, 10.1001/archpsyc.60.9.921 · DOI · Paper page
- Simon, 2007, Risk of suicide attempt and suicide death in patients treated for bipolar disorder I, Bipolar Disord, 9, 526, 10.1111/j.1399-5618.2007.00408.x · DOI · Paper page
- Goldstein, 2012, Predictors of prospectively examined suicide attempts among youth with bipolar disorder, Arch Gen Psychiatry, 69, 1113, 10.1001/archgenpsychiatry.2012.650 · DOI · Paper page
- Angst, 2005, Suicide in 406 mood-disorder patients with and without long-term medication: 40 to 44 year follow-up, Arch Suicide Res, 9, 279, 10.1080/13811110590929488 · DOI · Paper page
- Schaffer, 2012, CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders, Ann Clin Psychiatry, 24, 6
- Perugi, 2002, Obsessive-compulsive-bipolar comorbidity: systematic exploration of clinical features and treatment outcome, J Clin Psychiatry, 63, 1129, 10.4088/JCP.v63n1207 · DOI · Paper page
- Uguz, 2010, Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder, Gen Hosp Psychiatry, 32, 556, 10.1016/j.genhosppsych.2010.07.004 · DOI
- Winkler, 2003, Clonazepam in the long-term treatment of patients with unipolar depression, bipolar or schizoaffective disorder, Eur Neuropsychopharmacol, 13, 129, 10.1016/S0924-977X(02)00174-8 · DOI
- Sachs, 1990, Use of clonazepam for bipolar affective disorder, J Clin Psychiatry, 51, 31
- Perugi, 2010, Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: 3-year “open” follow-up study, Eur Arch Psychiatry Clin Neurosci, 260, 553, 10.1007/s00406-010-0109-y · DOI
- Tohen, 2007, Effect of comorbid anxiety on treatment response in bipolar depression, J Affect Disord, 104, 137, 10.1016/j.jad.2007.03.014 · DOI · Paper page
- Provencher, 2011, Psychotherapies for comorbid anxiety in bipolar spectrum disorders, J Affect Disord, 133, 371, 10.1016/j.jad.2010.10.040 · DOI
- Morishita, 2009, Clonazepam as a therapeutic adjunct to improve management of depression: brief review, Hum Psychopharmacol, 24, 191, 10.1002/hup.1015 · DOI · Paper page
- Vázquez, 2014, Pharmacological treatment for bipolar depression, Adv Psychiatr Treatment, 10.1192/apt.bp.113.011460 · DOI
- Gao, 2010, Comorbid anxiety and substance use disorders associated with a lower use of mood-stabilizers in patients with rapid-cycling bipolar disorder: descriptive analysis of cross-sectional data of 566 patients, Int J Clin Pract, 64, 336, 10.1111/j.1742-1241.2009.02284.x · DOI
- Fava, 2001, Cognitive-behavioral management of patients with bipolar disorder who relapsed while on lithium prophylaxis, J Clin Psychiatry, 62, 556, 10.4088/JCP.v62n07a10 · DOI · Paper page
- Lam, 2003, Randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year, Arch Gen Psychiatry, 60, 145, 10.1001/archpsyc.60.2.145 · DOI · Paper page
- Singh, 2006, Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials, Bipolar Disord, 8, 696, 10.1111/j.1399-5618.2006.00371.x · DOI · Paper page
- McDougle, 1991, Controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy, J Clin Psychopharmacol, 11, 175, 10.1097/00004714-199106000-00005 · DOI · Paper page
- Pigott, 1991, Controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder, J Clin Psychopharmacol, 11, 242, 10.1097/00004714-199108000-00004 · DOI · Paper page
- Uhde, 1988, Lack of efficacy of carbamazepine in the treatment of panic disorder, Am J Psychiatry, 145, 1104, 10.1176/ajp.145.9.1104 · DOI · Paper page
- Hertzberg, 1999, Preliminary study of lamotrigine for the treatment of posttraumatic stress disorder, Biol Psychiatry, 45, 1226, 10.1016/S0006-3223(99)00011-6 · DOI · Paper page
- Ameringen, 2004, Antiepileptic drugs in the treatment of anxiety disorders: role in therapy, Drugs, 64, 2199, 10.2165/00003495-200464190-00004 · DOI
- Keck, 2006, Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders, J Clin Psychiatry, 67, 8
- Mula, 2007, Role of anticonvulsant drugs in anxiety disorders: critical review of the evidence, J Clin Psychopharmacol, 27, 263, 10.1097/jcp.0b013e318059361a · DOI · Paper page
- Pande, 1999, Treatment of social phobia with gabapentin: placebo-controlled study, J Clin Psychopharmacol, 19, 341, 10.1097/00004714-199908000-00010 · DOI · Paper page
- Pande, 2000, Placebo-controlled study of gabapentin treatment of panic disorder, J Clin Psychopharmacol, 20, 467, 10.1097/00004714-200008000-00011 · DOI · Paper page
- Strawn, 2007, Treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic, Neuropsychiatr Dis Treat, 3, 237, 10.2147/nedt.2007.3.2.237 · DOI
- Bowden, 2007, Spectrum of effectiveness of valproate in neuropsychiatry, Expert Rev Neurother, 7, 9, 10.1586/14737175.7.1.9 · DOI
- Aliyev, 2008, Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study, Eur Psychiatry, 23, 109, 10.1016/j.eurpsy.2007.08.001 · DOI · Paper page
- Vulink, 2011, Review of atypical antipsychotics in anxiety, Eur Neuropsychopharmacol, 21, 429, 10.1016/j.euroneuro.2010.12.007 · DOI
- Reich, 2004, Preliminary study of risperidone in the treaetment of post-traumatic stress dusirder related to childhood abuse in women, J Clin Psychiatry, 65, 1601, 10.4088/JCP.v65n1204 · DOI · Paper page
- Bartzokis, 2005, Adjunctive risperidone in the treatment of chronic combat-related post-traumatic stress disorder, Biol Psychiatry, 57, 474, 10.1016/j.biopsych.2004.11.039 · DOI · Paper page
- Shapira, 2004, Double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder, Biol Psychiatry, 55, 553, 10.1016/j.biopsych.2003.11.010 · DOI
- Butterfield, 2001, Olanzapine in the treatment of post-traumatic stress disorder: pilot study, Int Clin Psychopharmacol, 16, 197, 10.1097/00004850-200107000-00003 · DOI · Paper page
- Stein, 2002, Adjunctive olanzapine for SSRI-resistant combat-related PTSD: double-blind, placebo-controlled study, Am J Psychiatry, 159, 1777, 10.1176/appi.ajp.159.10.1777 · DOI · Paper page
- Katzman, 2011, Aripiprazole: clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness, J Affect Disord, 128, S11, 10.1016/S0165-0327(11)70004-0 · DOI
- Kessler, 2003, Epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication, JAMA, 289, 3095, 10.1001/jama.289.23.3095 · DOI · Paper page
- Altmaca, 2002, Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: single-blind, placebo-controlled study, Int Clin Psychopharmacol, 17, 115, 10.1097/00004850-200205000-00004 · DOI · Paper page
- Gao, 2009, Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders, Expert Rev Neurother, 9, 1147, 10.1586/ern.09.37 · DOI · Paper page
- Zarate, 2008, Riluzole in psychiatry: systematic review of the literature, Expert Opin Drug Metab Toxicol, 4, 1223, 10.1517/17425255.4.9.1223 · DOI · Paper page
- Papolos, 2013, Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype, J Affect Disord, 147, 431, 10.1016/j.jad.2012.08.040 · DOI
- Prasko, 2007, Effect of repetitive transcranial magnetic stimulation (rTMS) added on to serotonin reuptake inhibitors in patients with panic disorder: randomize, double-blind, sham-controlled study, Neuro Endocrinol Lett, 1, 33
- George, 2009, Controversy: repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treatment psychiatric diseases (depression, mania, schizophrenia, obsessive-compulsive disorder, panic, posttraumatic stress disorder), Brain Stimul, 2, 14, 10.1016/j.brs.2008.06.001 · DOI · Paper page
- Paes, 2011, Value of repetitive transcranial magnetic stimulation (rTMS) for the treatment of anxiety disorders: integrative review, CNS Neurol Disord Drug Targets, 10, 610, 10.2174/187152711796234943 · DOI · Paper page
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationAmerio, A., Stubbs, B., Odone, A., Tonna, M., Marchesi, C., & Ghaemi, S. N. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.005 · Cited by 92
Psychological therapy for anxiety in bipolar spectrum disorders: A systematic review
Stratford, H. J., Cooper, M. J., Di Simplicio, M., Blackwell, S. E., & Holmes, E. A. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.11.002 · Cited by 63
Gates, M., Turney, A., Ferguson, E., Walker, V., & Staples-Horne, M. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14030317 · Cited by 58
Pavlova, B., Perlis, R. H., Mantere, O., Sellgren, C. M., Isometsä, E., Mitchell, P. B., Alda, M., & Uher, R. (2017) · Psychological Medicine · doi:10.1017/s0033291716003135 · Cited by 55
“As mood-stabilizing medication can also have anxiolytic effects (Vazquez et al. 2014), it is possible that the rates of current anxiety disorders during euthymia are underestimated.”
Background
Metadata
- Authors
- Vázquez, G. H., Baldessarini, R. J., & Tondo, L.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2014-03
- Volume
- 31
- Issue
- 3
- Pages
- 196-206
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W1576109028
- Cited by
- 93
- References
- 40
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 549 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.